Imperative Care announced new real-world data evaluating ADAPT 2.0, a next-generation approach to stroke treatment. ADAPT (A Direct Aspiration First Pass Technique) 2.0 combines 0.088” intracranial access, asymmetric aspiration, and the continuous dual aspiration technique (CDAT) to provide fast and effective clot removal. Campbell, … [Read more...] about Imperative Care reports positive results for next-gen stroke aspiration approach
Technologies & Devices
CMS adds reimbursement for cardiac ablation in ASCs
The Centers for Medicare and Medicaid Services (CMS) has provided a major reimbursement update for cardiac ablation technologies. In its 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, CMS added cardiac catheter ablation procedures to its ASC-covered procedures list. This … [Read more...] about CMS adds reimbursement for cardiac ablation in ASCs
Okami Medical names former Inari CEO to corner office, raises $45M
Okami Medical announced today that it appointed a new CEO alongside the closing of an oversubscribed $45 million financing. Aliso Viejo, California-based Okami tapped Drew Hykes as its new president and CEO. It also appointed Bill Hoffman as chair of its board. Hykes previously served as the CEO of Inari Medical, a maker of solutions for … [Read more...] about Okami Medical names former Inari CEO to corner office, raises $45M
VenstraMedical picks up investment for ventricular assist device
VenstraMedical announced today that it secured an investment to accelerate the development of its percutaneous ventricular assist device (pVAD). Highcroft Capital, a Minnesota-based venture capital firm specializing in medtech innovation, delivered the undisclosed investment. It supports the Newcastle, Australia-based company’s low-profile, … [Read more...] about VenstraMedical picks up investment for ventricular assist device
Merit Medical to launch Wrapsody endoprosthesis in U.S. after CMS defers reimbursement decision
Merit Medical Systems (Nasdaq:MMSI) announced that its application for reimbursement for its Wrapsody procedures requires further CMS consideration. As a result, the company plans to go ahead with the U.S. rollout for the cell-impermeable endoprosthesis (CIE). "We have elected to withdraw our application for TPT incremental payment and intend … [Read more...] about Merit Medical to launch Wrapsody endoprosthesis in U.S. after CMS defers reimbursement decision
Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal
Boston Scientific [WtwhTicker symbol="BSX"](NYSE: BSX)[/WtwhTicker] today announced a catheter development and commercialization deal with Siemens Healthineers. The deal centers around the workflow development and commercialization of Siemens Healthineers' AcuNav 4D intracardiac echocardiography (ICE) catheter. AcuNav 4D ICE technology is … [Read more...] about Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal
Boston Scientific enrolls first patient in AFib mapping study using OptiMap, Farapulse
A Boston Scientific [WtwhTicker symbol="BSX"](NYSE: BSX)[/WtwhTicker] official announced the enrollment of the first patients in the OPTIMIZE randomized controlled clinical trial. On LinkedIn, Nick Spadea-Anello, the company’s president of Electrophysiology, announced the enrollment in the trial. He said Dr. Oussama Wazni, global principal … [Read more...] about Boston Scientific enrolls first patient in AFib mapping study using OptiMap, Farapulse
CardioFocus enrolls first patients in PFA trial as it seeks European approval
CardioFocus announced today that it initiated clinical trials for its next-generation pulsed field ablation (PFA) technologies. The company kicked off its CE mark pivotal trial for the QuickShot Nav large-area focal PFA catheter and its next-generation CardioWave PFA system. Dr. Ante Anić leads the study, which enrolled the first patients at KBC … [Read more...] about CardioFocus enrolls first patients in PFA trial as it seeks European approval
Galvanize reports promising early results for pulsed electric field ablation for oncology
Galvanize Therapeutics today announced the publication of positive six-month results from its AFFINITY clinical trial in the medical journal Cancers. AFFINITY, a prospective, non-randomized, open-label, single-arm study evaluates the safety and feasibility of the company's Aliya platform. Aliya, a pulsed electric field (PEF) system, could … [Read more...] about Galvanize reports promising early results for pulsed electric field ablation for oncology
AVS reports positive results for pulsatile IVL tech
Amplitude Vascular Systems (AVS) today announced findings from the first 95 patients treated in its POWER PAD II U.S. pivotal study. POWER PAD II evaluates the company's pulsatile intravascular lithotripsy (PIVL) therapy. It assesses the safety and efficacy of the Pulse IVL system for treating moderate-to-severely calcified peripheral arterial … [Read more...] about AVS reports positive results for pulsatile IVL tech
